Millions worldwide suffer from mental health disorders like anxiety, panic disorder, and agoraphobia, but access to traditional therapy is limited by long wait times and accessibility issues. Traditional treatments often require in-person visits, which can be difficult for those with mobility issues or those who live in remote areas.

Sympatient offers Invirto, a digital therapeutic (DTx) that combines virtual reality (VR) exposure therapy with app-based cognitive behavioral therapy (CBT) to treat anxiety disorders. Patients can conduct therapy sessions from their homes, offering a flexible and accessible alternative to traditional in-person therapy. The platform integrates with therapists, allowing them to optimize treatment plans and offer additional modules. Through data-driven therapy models, Invirto enables personalized treatment tailored to individual patient needs, and has demonstrated a significant reduction in symptom burden in clinical studies.

VR-based exposure therapy for agoraphobia, social phobia, and panic disorder

App-based CBT exercises and techniques

Personalized treatment plans based on patient data

Integration with therapists for optimized care

Remote monitoring of patient progress

Available as a DiGA, fully reimbursed for 72 million Germans with statutory health insurance

Compliant with data privacy regulations

The primary audience includes individuals with anxiety disorders, psychotherapists, physicians, and health insurance providers seeking innovative and effective mental health solutions.

Sympatient generates revenue through reimbursement as a DiGA (Digitale Gesundheitsanwendung) in Germany, and through integrated care contracts with health insurance companies.